DK303689A - 1,7-disubstituerede 6-fluor-1,4-dihydro-quinol-4-on-3-carboxylsyre-forbindelser, antibakterielle praeparater indeholdende disse samt n-cyclopropyl-4-fluor-3-halogenanilin-mellemprodukter og fremgangsmaade til fremstilling deraf - Google Patents

1,7-disubstituerede 6-fluor-1,4-dihydro-quinol-4-on-3-carboxylsyre-forbindelser, antibakterielle praeparater indeholdende disse samt n-cyclopropyl-4-fluor-3-halogenanilin-mellemprodukter og fremgangsmaade til fremstilling deraf Download PDF

Info

Publication number
DK303689A
DK303689A DK303689A DK303689A DK303689A DK 303689 A DK303689 A DK 303689A DK 303689 A DK303689 A DK 303689A DK 303689 A DK303689 A DK 303689A DK 303689 A DK303689 A DK 303689A
Authority
DK
Denmark
Prior art keywords
fluoro
malane
halogene
quinol
disubstituted
Prior art date
Application number
DK303689A
Other languages
English (en)
Other versions
DK303689D0 (da
Inventor
Paul Robert Mcguirk
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK303689D0 publication Critical patent/DK303689D0/da
Publication of DK303689A publication Critical patent/DK303689A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/43Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C211/44Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
    • C07C211/52Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/30Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and unsaturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK303689A 1988-06-21 1989-06-20 1,7-disubstituerede 6-fluor-1,4-dihydro-quinol-4-on-3-carboxylsyre-forbindelser, antibakterielle praeparater indeholdende disse samt n-cyclopropyl-4-fluor-3-halogenanilin-mellemprodukter og fremgangsmaade til fremstilling deraf DK303689A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/209,660 US5039682A (en) 1988-06-21 1988-06-21 6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acid derivatives and intermediates therefor

Publications (2)

Publication Number Publication Date
DK303689D0 DK303689D0 (da) 1989-06-20
DK303689A true DK303689A (da) 1989-12-22

Family

ID=22779707

Family Applications (1)

Application Number Title Priority Date Filing Date
DK303689A DK303689A (da) 1988-06-21 1989-06-20 1,7-disubstituerede 6-fluor-1,4-dihydro-quinol-4-on-3-carboxylsyre-forbindelser, antibakterielle praeparater indeholdende disse samt n-cyclopropyl-4-fluor-3-halogenanilin-mellemprodukter og fremgangsmaade til fremstilling deraf

Country Status (7)

Country Link
US (1) US5039682A (da)
EP (1) EP0348088A1 (da)
JP (1) JPH07121914B2 (da)
CA (1) CA1334756C (da)
DK (1) DK303689A (da)
FI (1) FI93008C (da)
PT (1) PT90900B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0228178A (ja) * 1988-04-23 1990-01-30 Toyama Chem Co Ltd 新規なピリドンカルボン酸誘導体およびその塩並びにそれらの製造法
EP0997466A1 (en) * 1988-10-24 2000-05-03 PROCTER & GAMBLE PHARMACEUTICALS, INC. Novel antimicrobial lactam-quinolones
KR100236852B1 (ko) * 1992-10-09 2000-03-02 나가야마 오사무 플루오로 퀴놀린 유도체
ES2050613B1 (es) * 1992-10-16 1996-03-16 Iteve S A Nuevo procedimiento para la preparacion de derivados del acido 1-ciclopropil-3-quinolincarboxilico.

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3472859A (en) * 1966-11-01 1969-10-14 Sterling Drug Inc 1-alkyl-1,4-dihydro-4-oxo-3 quinoline-carboxylic acids and esters
US3907808A (en) * 1971-05-17 1975-09-23 Sterling Drug Inc 1,4-Dihydro-4-oxo-7-pyridyl-3-quinolinecarboxylic acid derivatives
US3753993A (en) * 1971-05-17 1973-08-21 Sterling Drug Inc 1,4-dihydro-4-oxo-7-pyridyl-3-quinoline-carboxylic acid derivatives
CA1034124A (en) * 1973-05-11 1978-07-04 Ciba-Geigy Ag Process for the manufacture of new quinolines
US4146625A (en) * 1976-07-16 1979-03-27 E. I. Du Pont De Nemours And Company Quinolonecarboxylic acids for control of bacterial diseases in plants
JPS5653656A (en) * 1979-10-05 1981-05-13 Tanabe Seiyaku Co Ltd Quinoline derivative and its preparation
US4670444B1 (en) * 1980-09-03 1999-02-09 Bayer Ag and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds
US4665079A (en) * 1984-02-17 1987-05-12 Warner-Lambert Company Antibacterial agents
DE3318145A1 (de) * 1983-05-18 1984-11-22 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3441788A1 (de) * 1984-11-15 1986-05-15 Bayer Ag, 5090 Leverkusen Alkyl-1-cyclopropyl-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
US4623650A (en) * 1984-12-06 1986-11-18 Pfizer Inc. Antibiotic derivatives of 7-phenyl-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids
US4636506A (en) * 1984-12-06 1987-01-13 Pfizer, Inc. 7-heterocyclic-1,4-dihydroquinolones
FR2574404B1 (fr) * 1984-12-12 1987-04-24 Provesan Sa Derives 1-substitues de l'acide 6-fluoro-7-(pyrrol-1-yl)-1,4-dihydro-4-oxoquinoleine-3-carboxylique, leur preparation et leur application en tant que medicaments
JPH0649671B2 (ja) * 1984-12-17 1994-06-29 杏林製薬株式会社 アニリン類とその製造方法
JPS61143363A (ja) * 1984-12-17 1986-07-01 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体の製造方法
JPS61143364A (ja) * 1984-12-17 1986-07-01 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体の製造方法
US4578473A (en) * 1985-04-15 1986-03-25 Warner-Lambert Company Process for quinoline-3-carboxylic acid antibacterial agents
US4772706A (en) * 1986-01-13 1988-09-20 Warner-Lambert Company Process for quinoline-3-carboxylic acid antibacterial agents
JPH089597B2 (ja) * 1986-01-21 1996-01-31 杏林製薬株式会社 選択毒性に優れた8‐アルコキシキノロンカルボン酸およびその塩並びにその製造方法
FR2594439B1 (fr) * 1986-02-19 1989-04-21 Vetoquinol Sa Nouveaux derives ester, thioester et amide de quinolone, leur procede de preparation et leur application en therapeutique
JPS62205060A (ja) * 1986-03-04 1987-09-09 Kyorin Pharmaceut Co Ltd 8位置換キノロンカルボン酸誘導体
US4771055A (en) * 1986-07-28 1988-09-13 Warner-Lambert Company 7-[[3-(aminomethyl)-3-alkyl]-1-pyrrolidinyl]-quinoline-carboxylic acids
DE3641661A1 (de) * 1986-12-05 1988-06-30 Bayer Ag Verfahren zur herstellung von chinoloncarbonsaeureestern
US4929613A (en) * 1987-08-26 1990-05-29 Warner-Lambert Company Antibacterial agents
JP2598921B2 (ja) * 1987-10-05 1997-04-09 富山化学工業株式会社 新規なキノリン誘導体およびその塩
DE3811341A1 (de) * 1987-10-09 1989-04-27 Bayer Ag In 7-stellung c-verknuepfte chinolon- und 1,8-naphthyridin-4-on-carbonsaeure und ein verfahren zu ihrer herstellung
US4880814A (en) * 1987-11-13 1989-11-14 Abbott Laboratories 7-cycloalkyl naphthyridines
US4945160A (en) * 1988-11-22 1990-07-31 Warner-Lambert Company Preparation of certain 7-substituted quinolones

Also Published As

Publication number Publication date
FI893030A0 (fi) 1989-06-20
PT90900A (pt) 1989-12-29
FI93008B (fi) 1994-10-31
DK303689D0 (da) 1989-06-20
CA1334756C (en) 1995-03-14
FI93008C (fi) 1995-02-10
US5039682A (en) 1991-08-13
JPH07121914B2 (ja) 1995-12-25
FI893030A (fi) 1989-12-22
EP0348088A1 (en) 1989-12-27
PT90900B (pt) 1995-03-01
JPH0245469A (ja) 1990-02-15

Similar Documents

Publication Publication Date Title
DK359986A (da) Phenylethere, fremgangsmaader til fremstilling samt farmaceutiske midler indeholdende disse
DK108388A (da) Piperazinylalkylheterocycliske forbindelser og farmaceutiske praeparater indeholdende disse
NO885327L (no) Kjemiske preparater.
DK231687A (da) Heterocykliske forbindelser, deres fremstilling og anvendelse, samt laegemidler indeholdende disse forbindelser
DK272289D0 (da) Phosphalidylforbindelser og praeparater indeholdende disse til anvendelse som anti-virale midler
DK164594C (da) 1,4-dihydro-pyridin-3,5-yl-dicarboxylsyrederivater, farmaceutiske praeparater indeholdende disse derivater samt fremgangsmaade til fremstilling deraf
DK160986C (da) Ferrikomplekser, deres anvendelse samt farmaceutiske praeparater indeholdende disse
DK165367C (da) Imidazolylalkylguanidinderivater, fremgangsmaade til fremstilling heraf samt laegemidler indeholdende disse forbindelser
DK78888D0 (da) Arylpiperazinylalkylenphenyl-heterocycliske forbindelser og farmaceutiske praeparater indeholdende disse
DK188286D0 (da) Phenylalkyl-2,3-dihydrobenzofuraner og analoge heraf samt praeparater indeholdende disse forbindelser
DK66086D0 (da) Dihydropyridiner, fremgangsmaader til fremstilling heraf samt farmaceutiske midler indeholdende disse
DK143188A (da) Farmaceutiske praeparater indeholdende pyranoquinolinforbindelser samt deres anvendelse
DK533087D0 (da) Anthracyklinglykosider, deres fremstilling, mellemprodukter deraf samt praeparater indeholdende disse og deres anvendelse
DK307085D0 (da) 4-phenyl-2-trifluormethyl-1,3-dioxan-5-ylheptensyrederivater, fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse
DK166485D0 (da) Antibiotiske og antitumoraktive forbindelser cl-1724, praeparater indeholdende disse samt fremgangsmaade til fremstilling deraf
DK303689D0 (da) 1,7-disubstituerede 6-fluor-1,4-dihydro-quinol-4-on-3-carboxylsyre-forbindelser, antibakterielle praeparater indeholdende disse samt n-cyclopropyl-4-fluor-3-halogenanilin-mellemprodukter og fremgangsmaade til fremstilling deraf
DK21785A (da) Dihydropyridinforbindelser og farmaceutiske praeparater indeholdende disse
DK81185A (da) Carboxicam-enolester-forbindelser og farmaceutiske praeparater indeholdende disse
DK65986A (da) Dihydropyridiner, fremgangsmaader til fremstilling heraf samt farmaceutiske midler indeholdende disse
DK501385D0 (da) 1,3,4-thiadiazolderivater, fremgangsmaade til fremstilling heraf samt laegemidler indeholdende disse forbindelser
DK51785D0 (da) 1,4-aminoalkylamino-9h-thioxanthen-9-oner, laegemidler indeholdende disse samt fremgangsmaade til fremstilling deraf
NO911243L (no) Kjemiske preparater.
NO903967L (no) Dihydrocaffeinsyrederivater og farmasoeytiske preparater som inneholder disse.
DK379287A (da) 1,3-propandiaminderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse
DK696888A (da) Polynucleotidanaloge og praeparater indeholdende saadanne forbindelser.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment